[1] Badiee P,Alborzi A.Invasive fungal infections in renal transplant recipients[J].Exp Clin Transplant,2011,9(6):355-362.
[2] Einollahi B,Lessan-Pezeshki M,Pourfarziani V,et al.Invasive fungal infections following renal transplantation:a review of 2410 recipients[J].Ann Transplant,2008,13(4):55-58.
[3] Diamond RD.Cryptocoecus neoformans[M]//Mandell GL,Bennet JE,Dolin R,eds.Principles and practice of infectious diseases.5th edn.Philadelphia:Churchill Livingstone,2000:3126-3136.
[4] Singh N,Alexander BD,Lortholary O,et al.Cryptococcus neoformans in organ transplant recipients:impact of calcineurin-inhibitor agents on mortality[J].J Infect Dis,2007,195(5):756-764.
[5] Pan B,Chen M,Jia H,et al.Multiple subcutaneous abscesses:a rarepresentation of cutaneous cryptococcosis[J].Indian J Dermatol Venereol Leprol,2013,79(1):118-119.
[6] Lopez FA,Sanders CV.Dermatologie infections in the immunocompmmised(non-HIV)host[J].Infect Dis Clin North Am,2001,15(2):671-702.
[7] Husain S,Wagener MM,Singh N.Cryptococcus neoformans infection in organ transplant recipients:variables influencing clinical characteristics and outcome[J].Emerg Infect Dis.2001,7(3):375-381.
[8] 许书添,谢红浪,陈劲松,等.移植术后新生隐球菌病的临床特点及转归[J].肾脏病与透析肾移植杂志,2012,21(1):19-23.
[9] 杨雅骊,都琳温海,等.肾移植术后隐球菌性脑膜炎的临床分析[J].中国真菌学杂志,2013,8(2):78-82.
[10] Mody CH,Toewns GB,Lipscomb MF.Cyclosporine A inhibits the growth of Cryptococcus neoformans on a murine modal[J].Infect Immun,1988,56(1):7-12.
[11] Odom AM,Del Poeta M,Perfect J,et al.The immunosuppressant FK506 and its nonimmunosupressive analog L-685,818 ale toxic to Cryptococeus neoformans by inhibition of a common target protein[J].Antimicrob Agents Chemother,1997,41(1):156-161.
[12] Cruz MC,Del Poeta M,Wang P,et al.Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin[J].Antimicrob Agents Chemother,2000,44:143-149.
[13] Einollahi B,Lessan-Pezeshki M,Pourfarziani V,et al.Invasive fungal infections following renal transplantation:a review of 2410 recipients[J].Ann Transplant,2008,13(4):55-58.
[14] Neuville S,Dromer F,Morin O,et al.Primary cutaneous cryptococcosis:a distinct clinical entity[J].Clin Infect Dis,2003,36(3):337-347.
[15] Blankenship JR,Singh N,Alexander BD,et al.Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to ealeineurin inhibitors by current immunosuppressive regimens[J].J Clin Microbiol,2005,43(1):464-467.
[16] Perfect JR,Dismukes WE,Dromer F,et al.Clinical practice guidelines for the management of cryptococcal disease:2010 update by the infectious diseases society of America[J].Clin Infect Dis,2010,50(3):2912322.
[17] MacDougall L,Kidd SE,Galanis E,et al.Spread of Cryptococcus gattii in British Columbia,Canada,and detection in the Pacific Northwest,USA[J].Emerg Infect Dis,2007,13(1):42-50. |